Tag: Idelalisib

Two trials: acalabrutinib in CLL

Presented By
Prof. John Byrd, Ohio State University Comprehensive Cancer Centre, USA
Trial
Phase 2, ACE-CL-001, ASCEND
Conference
EHA 2020
Type
Peer-reviewed article

9 September 2020 12:19
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com